Article Sidebar

Published: 2026-07-24
Abstract Views: 0
DOI: https://doi.org/10.52163/yhc.v67iCD9.5803
Issue
Tập 67 Số CĐ9 - HNKH Hội Y học Giới tính
Section
Articles
How to Cite
Minh, T. H., Anh, T. L. D., Phong, T. T., Thành, N. T., Trung, N. Q., Quang, N. T., Kiệt, L. V. T., Phát, T. T., & Hải, T. H. (2026). OUTCOMES OF ARTIFICIAL CORPUS CAVERNOSUM IMPLANTATION FOR ERECTILE DYSFUNCTION AT PEOPLE’S HOSPITAL 115. Vietnam Journal of Community Medicine, 67(CD9). https://doi.org/10.52163/yhc.v67iCD9.5803

OUTCOMES OF ARTIFICIAL CORPUS CAVERNOSUM IMPLANTATION FOR ERECTILE DYSFUNCTION AT PEOPLE’S HOSPITAL 115

Truong Hoang Minh1, Tran Le Duy Anh1, Tran Thanh Phong1, Ngo Tri Thanh1, Ngo Quang Trung1, Nguyen Thanh Quang1, Le Vuong Tuan Kiet1, To Thanh Phat1, Truong Hoang Hai1
1 115 People’s Hospital

Main Article Content

Abstract

Objective: To evaluate the outcomes of inflatable penile prosthesis (IPP) implantation focusing on surgical efficacy, complication rates, and satisfaction of patients and their partners.


Methods: A prospective descriptive case series of 30 patients who underwent primary IPP implantation for erectile dysfunction at 115 People’s Hospital from July 2019 to March 2026. Satisfaction was assessed using QoLSPP questionnaires.


Results: The mean age of the patients was 56.63 ± 13.36 years. Device functionality was optimal in 100% of cases, with a mean operative time of 87.33 minutes. There were no intraoperative complications. The postoperative complication rate was 10% (3 cases), comprising 1 instance of bleeding and 2 cases of postoperative fever, all managed successfully with medical treatment. During follow-up, 100% of patients and partners reported high satisfaction with sexual function restoration.


Conclusion: IPP implantation is a safe and highly effective treatment for erectile dysfunction, offering excellent complication control and outstanding satisfaction for both patients and partners.

Article Details

Keywords

Penile prosthesis, erectile dysfunction, surgical outcomes.

References

[1] Salonia A et al. EAU guidelines on sexual and reproductive health, 2026. doi: 10.1016/j.euf.2026.04.015
[2] Di Pierro G.B et al. Mid-term outcomes of minimally invasive infrapubic approach for inflatable penile prosthesis implantation: a single-center study and literature review. Andrology, 2024, 12 (3): 624-632. doi: 10.1111/andr.13497.
[3] Burnett A.L et al. Erectile dysfunction: AUA guideline. J Urol, 2018, 200 (3): 633-641. doi: 10.1016/j.juro.2018.05.004.
[4] Stern N, Bajic P, Campbell J et al. Evolving medical management of erectile dysfunction: recommendations from the fifth International Consultation on Sexual Medicine (ICSM 2024). Sex Med Rev, 2025, 13 (4): 513-537. doi: 10.1093/sxmrev/qeaf035.
[5] Hawks-Ladds N, Babar M, Labagnara K et al. Risk factors for reoperation of inflatable penile prosthesis among an ethnically diverse urban population in a high-volume center. Int J Impot Res, 2025, 37 (1): 37-44. doi: 10.1038/s41443-024-00966-8.
[6] Ivan S, Pryor J, Maffucci F, Simhan J. Reservoir placement options: a state of the art review. Int J Impot Res, Published online May 12, 2025. doi: 10.1038/s41443-025-01082-x.
[7] Atwater B, Krug A, Gross M.S, Marty-Roix R, Chapin L, Morey A.F. A review of the safety and efficacy of inflatable penile prosthesis ectopic reservoir placement. Sex Med Rev, 2025, 3 (1): 20-32. doi: 10.1093/sxmrev/qeae067.
[8] Miller L.E, Khera M, Bhattacharyya S, Patel M, Nitschelm K, Burnett A.L. Long-term survival rates of inflatable penile prostheses: systematic review and meta-analysis. Urology, 2022, 166: 6-10. doi: 10.1016/j.urology.2022.03.026.
[9] Knoll P, Rai S, Talluri S et al. A survey of usage of penile prosthesis. J Sex Med, 2020, 17 (11): 2287-2290. doi: 10.1016/j.jsxm.2020.07.082
[10] Chierigo F, Capogrosso P, Dehò F et al. Long-term follow-up after penile prosthesis implantation-survival and quality of life outcomes. J Sex Med, 2019, 16 (11): 1827-1833. doi: 10.1016/j.jsxm.2019.08.001.